Pricing Log in Create free account

Hyperion DeFi, Inc. (HYPD) vs Mereo BioPharma Group plc - Sponsored ADR (MREO)

Hyperion DeFi, Inc. and Mereo BioPharma Group plc - Sponsored ADR are both Biotechnology companies. Hyperion DeFi, Inc. and Mereo BioPharma Group plc - Sponsored ADR are of similar size ($49.3M and $49.0M). Mereo BioPharma Group plc - Sponsored ADR has the higher net margin (0.00% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 14 metrics below, Hyperion DeFi, Inc. leads on 8 and Mereo BioPharma Group plc - Sponsored ADR on 6.

Valuation

Metric HYPD MREO Biotechnology median
P/E n/m n/m 8.50
P/S 28.74 n/m 9.71
P/B 0.39 1.68 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 7.98 n/m 0.64
EV/Sales 27.88 n/m 9.21
Earnings yield (217.96%) (58.20%) (33.15%)
Free cash flow yield (191.71%) (53.23%) (25.50%)

Profitability

Metric HYPD MREO Biotechnology median
Gross margin 78.35% 0.00% 65.16%
Operating margin 314.32% 0.00% 0.00%
Net margin (1,224.53%) 0.00% 0.00%
Free cash flow margin (5,509.35%) 0.00% 0.00%
Return on equity (24.63%) (67.85%) (56.36%)
Return on assets (20.32%) (57.73%) (48.04%)
Return on invested capital 2.73% 0.00% 0.00%

Growth

Metric HYPD MREO Biotechnology median
Revenue growth (TTM) 1,990.60% — 6.02%
EPS growth (last fiscal year) 84.28% 10.16% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HYPD MREO Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 2.34 5.88 4.72
Net debt to EBITDA (0.03) 1.04 0.96

Dividend

Metric HYPD MREO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HYPD MREO Biotechnology median
Market cap 48.95m 49.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack